Company news
Vigonvita Life Sciences Co., Ltd. news in 2026
Vigonvita Life Sciences Co., Ltd.'s news releases, calls and decks from 2026, newest first.
Next Day Disclosure Return
November 13, 2026
Voluntary announcement - (1) the new drug application (NDA) for semenafil hydrochloride tablets has been accepted by the department of health of hong kong, China and the pharmaceutical administration bureau of macao, China; and (2) clarification announcement in relation to the interim report for the six months ended June 30, 2026
November 12, 2026
Next Day Disclosure Return
November 12, 2026
Next Day Disclosure Return
November 10, 2026
Next Day Disclosure Return
November 6, 2026
Next Day Disclosure Return
November 5, 2026
Next Day Disclosure Return
November 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
November 4, 2026
Next Day Disclosure Return
November 3, 2026
Next Day Disclosure Return
November 2, 2026
Next Day Disclosure Return
October 30, 2026
Voluntary announcement - notice on voluntary extension of lock-up period by shareholders
October 30, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
October 6, 2026
2026 Interim report
September 30, 2026
Inside information - issuance of filing notice by the CSRC for the h share full circulation application of the company
June 29, 2026
Revised proxy form for the annual general meeting to be held on Tuesday, June 30, 2026
June 14, 2026